Virtu Financial LLC Mannkind Corp Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$3.34 - $4.29 $149,421 - $191,921	44,737 Added 87.16%	96,066 $350,000
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $200,696 - $279,743	51,329 New	51,329 $212,000
Q3 2022 Nov 07, 2022	BUY	$2.99 - $4.35 $271,680 - $395,254	90,863 Added 562.9%	107,005 $331,000
Q2 2022 Aug 09, 2022	BUY	$2.67 - $4.77 $43,099 - $76,997	16,142 New	16,142 $61,000
Q1 2022 May 17, 2022	SELL	$2.62 - $4.45 $47,631 - $80,901	-18,180 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.05 - $5.37 $26,924 - $35,699	6,648 Added 57.65%	18,180 $79,000
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $44,859 - $63,195	11,532 New	11,532 $50,000
Q1 2021 May 19, 2021	SELL	$3.14 - $6.14 $145,696 - $284,896	-46,400 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.79 - $4.04 $9,583 - $21,630	5,354 Added 13.04%	46,400 $145,000
Q3 2020 Dec 11, 2020	BUY	$1.56 - $2.08 $64,031 - $85,375	41,046 New	41,046 $77,000
Q3 2019 Nov 20, 2019	SELL	$1.04 - $1.44 $18,987 - $26,290	-18,257 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.09 - $1.88 $19,900 - $34,323	18,257 New	18,257 $21,000
Q1 2019 Apr 12, 2019	SELL	$1.14 - $2.25 $53,281 - $105,160	-46,738 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$1.02 - $2.05 $47,672 - $95,812	46,738 New	46,738 $50,000
Q3 2018 Nov 13, 2018	SELL	$1.01 - $2.19 $21,127 - $45,810	-20,918 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$1.59 - $2.38 $54,492 - $81,567	-34,272 Reduced 62.1%	20,918 $40,000
Q1 2018 May 14, 2018	BUY	$2.28 - $3.8 $125,833 - $209,722	55,190 New	55,190 $126,000
Q4 2017 Feb 09, 2018	SELL	$2.28 - $6.71 $207,974 - $612,066	-91,217 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.15 - $2.29 $104,899 - $208,886	91,217	91,217 $0

Others Institutions Holding MNKD

# of Institutions

248

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account